2021高技术发展报告

目录
自觉履行高水平科技自立自强的使命担当（代序）　侯建国　i
前言　中国科学院《高技术发展报告》课题组　vii
第一章　2020 年高技术发展综述　张久春　1
第二章　生物技术新进展　73
2.1　基因编辑技术新进展　李广磊　黄行许　75
2.2　干细胞与再生医学技术新进展　郑辉　裴端卿　82
2.3　合成生物学技术新进展　陈大明　熊燕　王勇　90
2.4　生物信息技术新进展　李栋　朱云平　贺福初　100
2.5　环境生物技术新进展　王伟伟　唐鸿志　刘双江　110
2.6　工业生物技术新进展　刘龙　刘延峰　陈坚　119
2.7　绿色材料的生物制造技术新进展　陈国强　郑爽　何宏韬　128
2.8　纳米生物技术新进展　陈义祥　张阳　王树涛　136
2.9　免疫治疗技术新进展　于益芝　曹雪涛　144
2.10　病原体防治技术新进展　朱力　王恒樑　陈薇　151
2.11　生物安全技术新进展　王磊　肖尧　武桂珍　161
第三章　生物技术产业化新进展　171
3.1　疫苗与生物创新药产业化新进展　李启明　173
3.2　现代中药产业化新进展　孙晓波　李耿　181
3.3　生物育种技术产业化新进展　薛勇彪　金京波　程佑发　王台　190
3.4　工业生物制造技术产业化新进展　汪琪琦　王钦宏　马延和　198
3.5　生物质能源技术产业化新进展　孙永明　209
3.6　环保生物资源挖掘与利用产业化新进展　王爱杰　黄聪　刘文宗　郜爽　侯雅男　217
3.7　食品生物技术产业化新进展　刘延峰　陈坚　226
第四章　医药制造业国际竞争力与创新能力评价　233
4.1　中国医药制造业国际竞争力评价　郭鑫　蔺洁　235
4.2　中国医药制造业创新能力评价　王孝炯　薛晓宇　259
第五章　高技术与社会　277
5.1　脑机接口技术的伦理挑战　马诗雯　周程　279
5.2　实验空间与有限责任：新兴科技的伦理与治理　王大洲　287
5.3　当代新兴增强技术及其社会影响　杨庆峰　295
5.4　基因增强技术的伦理担忧　朱慧玲　304
5.5　跨越边界：新冠病毒疫苗研发中的社会协作　张理茜　杜鹏　311
第六章　专家论坛　319
6.1　关于我国生物信息安全的战略思考　鲍一明　娄晓敏　肖景发　章张　赵文明　薛勇彪　321
6.2　传染病防控领域健康医疗大数据应用存在的问题及对策建议　刘民　梁万年　330
6.3　关于我国新冠病毒疫苗发展的战略思考　施一　335
6.4　新时期开展科技外交的影响因素和政策建议　罗晖　346
6.5　“十四五”时期促进生物经济发展的思考与建议　姜江　352
CONTENTS
Consciously Fulfill the Mission to Achieve Self-Reliance and Self-improvement in High-level Science and Technology　i
Introduction　vii
Chapter 1　Overview of High Technology Development in 2020　1
Chapter 2　Progress in Biotechnology　73
2.1　Gene Editing　75
2.2　Stem Cell and Regenerative Medicine　82
2.3　Synthetic Biology　90
2.4　Bioinformation Technology　100
2.5　Environmental Biotechnology　110
2.6　Industrial Biotechnology　119
2.7　Bioplastics Production Technology　128
2.8　Nano-biotechnology　136
2.9　Immunotherapy　144
2.10　Technologies in the Control and Prevention of Pathogens　151
2.11　Biosafety Technology　161
Chapter 3　Progress in Commercialization of Biotechnology　171
3.1　Commercialization of Vaccine and Bio-innovative Drugs　173
3.2　Commercialization of Modern Chinese Medicine　181
3.3　Commercialization of Biotech Seeds　190
3.4　Commercialization of Industrial Biomanufacturing　198
3.5　Commercialization of Biomass Energy Technologies　209
3.6　Commercialization of the Mining and Utilization in Environmental Biological Resources　217
3.7　Commercialization of Food Biotechnology　226
Chapter 4　Evaluation on Pharmaceutical Industry Competitiveness and Innovation Capacity　233
4.1　Evaluation on International Competitiveness of Chinese Pharmaceutical Industry　235
4.2　Evaluation on Innovation Capacity of Chinese Pharmaceutical Industry　259
Chapter 5　High Technology and Society　277
5.1　Ethical Challenges of Brain-Computer Interface Technology　279
5.2　Experimental Space and Limited Liability：Ethics and Governance of Emerging Science and Technologies　287
5.3　Contemporary Emerging Enhancement Technology and Its Influence　295
5.4　The Moral Concerns of Genetic Enhancement　304
5.5　Social Collaboration in Research and Development（R&D）of COVID-19 Vaccine 311
Chapter 6　Expert Forum　319
6.1　Strategic Thinking on Biological Information Security in China　321
6.2　Problems and Countermeasures in the Application of Healthcare Big Data in Infectious Disease Prevention and Control　330
6.3　Strategic Thinking on the Development of COVID-19 Vaccine in China　335
6.4　Influencing Factors and Policy Suggestions of Developing Science and Technology Diplomacy in the New Era　346
6.5　Thinkings and Recommendations on Promoting the Development of Bioeconomy in the 14th Five Year Plan Period　352